LCRF hosted our third annual Collectively Chicago occasion Could 15 in a lovely neighborhood in Evanston, IL. A bunch of sufferers, caregivers, healthcare suppliers, and others impacted by lung most cancers gathered at LeTour on the sunny night to attach and be taught extra concerning the newest in lung most cancers analysis.
Our panel of consultants was moderated by LCRF’s Chief Scientific Officer, Antoinette Wozniak, MD. Becoming a member of us as panelists have been Rajat Thawani, MBBS and Denise Rouse, MMSPA from UChicago Medication; and Mary J. Fidler, MD from Rush Medical Middle. Ms. Rouse supplied her perspective as a doctor assistant – a perspective that was new to LCRF Collectively.
The night was stuffed with impactful conversations earlier than, throughout and after the panel dialogue. Panelists shared their ideas, expertise, suggestions, and took common questions from the viewers. An attention-grabbing dialogue revolved round early-stage lung most cancers remedy, together with neoadjuvant, perioperative, and adjuvant therapies, in addition to remedy for EGFR- and ALK-positive lung cancers. The dialog on focused therapies delved into what physicians are doing for sufferers whose focused remedy stops controlling their most cancers. The panel additionally explored the negative effects of remedies, affected person reported outcomes, ADCs, small cell lung most cancers, screening, and supportive care choices.
Watch our calendar for different occasions close to you and upcoming #TogetherSeparately livestreams.
